Sinovac Biotech (SVA +6.7%) is trading higher after saying it's been selected by the Beijing...


Sinovac Biotech (SVA +6.7%) is trading higher after saying it's been selected by the Beijing Centers for Disease Control and Prevention as one of four manufacturers to supply a seasonal influenza vaccine to Beijing.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs